Clinical trial
Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell…
NCT00085930 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00085930 |
|---|---|
| Title | Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients |
| Official title | Administration of Peripheral Blood T-Cells and EBV Specific CTLs Transduced to Express GD-2 Specific Chimeric T Cell Receptors to Patients With Neuroblastoma |
| Acronym | NESTLES |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological |
| Interventions | EBV specific CTLs |
| Enrollment | 19 |
| Start date | Apr 1, 2003 |
| Primary completion | Jan 1, 2010 |
| Completion | Aug 1, 2025 |
| First posted | Jun 21, 2004 |
| Last update posted | Jan 7, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: